gene	chromosome	position	ref	alt	source	entryDate	sourceEvent	sourceUrls	nctId	title	acronym	genderCriterium	countriesAndCities	hospitalsPerCity	treatment	treatmentApproachesDrugClass	treatmentApproachesTherapy	applicableCancerType	applicableDoid	blacklistCancerTypes	efficacyDescription	efficacyDescriptionYear	evidenceLevel	evidenceLevelDetails	direction	evidenceUrls
BRAF	7	140453136	A	T	CKB_EVIDENCE	2021-02-03	variant	http							Vemurafenib			Skin Melanoma	X		efficacy evidence	2024	A	GUIDELINE	RESPONSIVE	http
BRAF	7	140453137	A	T	CKB_TRIAL	1970-01-01	variant	http	NCT1	study1	study11	female	Netherlands(Nijmegen;Maastricht)	Nijmegen(Radboud UMC),Maastricht(MUMC)	Vemurafenib			Solid tumor	X			2024	C	CLINICAL_STUDY	RESISTANT	http